DOI:
10.1055/s-00000007
Aktuelle Urologie
LinksClose Window
References
Herschorn S, Barkin J, Castro-Diaz D. et al.
A phase III, randomized, double-blind, parallel-group, placebo-controlled, multicentre study to assess the efficacy and safety of the beta(3) adrenoceptor agonist, mirabegron, in patients with symptoms of overactive bladder.
Urology 2013;
82: 313-320
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.